169 related articles for article (PubMed ID: 15763659)
21. How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer.
Couto JP; Prazeres H; Castro P; Lima J; Máximo V; Soares P; Sobrinho-Simões M
J Clin Pathol; 2009 May; 62(5):414-21. PubMed ID: 19147628
[TBL] [Abstract][Full Text] [Related]
22. BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas.
Lima J; Trovisco V; Soares P; Máximo V; Magalhães J; Salvatore G; Santoro M; Bogdanova T; Tronko M; Abrosimov A; Jeremiah S; Thomas G; Williams D; Sobrinho-Simões M
J Clin Endocrinol Metab; 2004 Sep; 89(9):4267-71. PubMed ID: 15356020
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.
Nikiforova MN; Nikiforov YE
Expert Rev Mol Diagn; 2008 Jan; 8(1):83-95. PubMed ID: 18088233
[TBL] [Abstract][Full Text] [Related]
24. BRAF mutation in thyroid cancer.
Xing M
Endocr Relat Cancer; 2005 Jun; 12(2):245-62. PubMed ID: 15947100
[TBL] [Abstract][Full Text] [Related]
25. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer.
Cheung CC; Carydis B; Ezzat S; Bedard YC; Asa SL
J Clin Endocrinol Metab; 2001 May; 86(5):2187-90. PubMed ID: 11344225
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous occurrence of PAX8-PPARg and RET-PTC3 rearrangements in a follicular variant of papillary thyroid carcinoma.
Caria P; Dettori T; Frau DV; Di Oto E; Morandi L; Parmeggiani A; Tallini G; Vanni R
Am J Surg Pathol; 2012 Sep; 36(9):1415-20. PubMed ID: 22895275
[TBL] [Abstract][Full Text] [Related]
27. [Pathogenesis of differentiated thyroid cancer (papillary and follicular)].
Maciel RM; Kimura ET; Cerutti JM
Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):691-700. PubMed ID: 16444351
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas.
Nikiforova MN; Caudill CM; Biddinger P; Nikiforov YE
Int J Surg Pathol; 2002 Jan; 10(1):15-22. PubMed ID: 11927965
[TBL] [Abstract][Full Text] [Related]
29. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.
Zhu Z; Gandhi M; Nikiforova MN; Fischer AH; Nikiforov YE
Am J Clin Pathol; 2003 Jul; 120(1):71-7. PubMed ID: 12866375
[TBL] [Abstract][Full Text] [Related]
30. Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas.
Kumagai A; Namba H; Saenko VA; Ashizawa K; Ohtsuru A; Ito M; Ishikawa N; Sugino K; Ito K; Jeremiah S; Thomas GA; Bogdanova TI; Tronko MD; Nagayasu T; Shibata Y; Yamashita S
J Clin Endocrinol Metab; 2004 Sep; 89(9):4280-4. PubMed ID: 15356022
[TBL] [Abstract][Full Text] [Related]
31. Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma.
Domingues R; Mendonça E; Sobrinho L; Bugalho MJ
Cytopathology; 2005 Feb; 16(1):27-31. PubMed ID: 15859312
[TBL] [Abstract][Full Text] [Related]
32. [Fine-needle aspiration cytology of thyroid nodules: molecular diagnostics in a routine diagnostic setting].
Eszlinger M; Neustadt M; Ruschenburg I; Neumann A; Franzius C; Adam S; Bacher K; Hach A; Hammoser R; Langvogt C; Molwitz T; Paschke R
Dtsch Med Wochenschr; 2014 Mar; 139(10):476-80. PubMed ID: 24570192
[TBL] [Abstract][Full Text] [Related]
33. Challenging dogma in thyroid cancer molecular genetics--role of RET/PTC and BRAF in tumor initiation.
Fagin JA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4264-6. PubMed ID: 15356019
[No Abstract] [Full Text] [Related]
34. [BRAF initiating mutations in the papillary thyroid carcinoma].
Rusinek D; Gubała E
Endokrynol Pol; 2006; 57(4):438-44. PubMed ID: 17006850
[TBL] [Abstract][Full Text] [Related]
35. Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.
Rossi M; Buratto M; Tagliati F; Rossi R; Lupo S; Trasforini G; Lanza G; Franceschetti P; Bruni S; Degli Uberti E; Zatelli MC
Thyroid; 2015 Feb; 25(2):221-8. PubMed ID: 25333496
[TBL] [Abstract][Full Text] [Related]
36. RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics.
Leeman-Neill RJ; Brenner AV; Little MP; Bogdanova TI; Hatch M; Zurnadzy LY; Mabuchi K; Tronko MD; Nikiforov YE
Cancer; 2013 May; 119(10):1792-9. PubMed ID: 23436219
[TBL] [Abstract][Full Text] [Related]
37. RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis.
Ciampi R; Nikiforov YE
Endocrinology; 2007 Mar; 148(3):936-41. PubMed ID: 16946010
[TBL] [Abstract][Full Text] [Related]
38. [Hyalinizing trabecular tumor of the thyroid. An overcautious designation of a benign thyroid tumour?].
Ting S; Puttinger C; Schmid KW; Sheu-Grabellus SY
Pathologe; 2012 Mar; 33(2):135-41. PubMed ID: 21842215
[TBL] [Abstract][Full Text] [Related]
39. The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells.
Melillo RM; Castellone MD; Guarino V; De Falco V; Cirafici AM; Salvatore G; Caiazzo F; Basolo F; Giannini R; Kruhoffer M; Orntoft T; Fusco A; Santoro M
J Clin Invest; 2005 Apr; 115(4):1068-81. PubMed ID: 15761501
[TBL] [Abstract][Full Text] [Related]
40. BRAF mutations are uncommon in papillary thyroid cancer of young patients.
Penko K; Livezey J; Fenton C; Patel A; Nicholson D; Flora M; Oakley K; Tuttle RM; Francis G
Thyroid; 2005 Apr; 15(4):320-5. PubMed ID: 15876153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]